Catalent (CTLT) PT Raised to $140 at Jefferies As COVID Tailwind to Last Another Year
Tweet Send to a Friend
Jefferies analyst David Windley raised the price target on Catalent (NYSE: CTLT) to $140.00 (from $115.00) after COVID appears to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
